LAS VEGAS--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, will present its clinically proven fish-skin graft ...

Symposia leadership and multiple accepted abstracts position intact fish skin at the forefront of evidence-based wound ...

Kerecis, the company pioneering the use of sustainably sourced fish-skin in cellular therapy and tissue regeneration, will showcase its intact fish-skin technology and highlight new clinical data on ...

The MarketWatch News Department was not involved in the creation of this content. The trial compared hospital stay duration of severely burned patients treated with intact fish-skin grafts and ...

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration, today ...

Real-world clinical trial shows superior clinical effectiveness of intact fish-skin grafts over standard care for treating severe, hard-to-heal Stage 3 and 4 pressure ulcers. Kerecis, the company ...

Kerecis, the company pioneering the use of sustainably sourced fish‑skin in tissue regeneration, announced today at the American Burn Association Annual Meeting, that new study data shows that intact ...

With this policy update, Kerecis fish-skin grafts — including the MariGen ® and Shield ® product lines — became available to tens of millions of additional Americans. In total, nearly 200 million ...

The MarketWatch News Department was not involved in the creation of this content. Real-world clinical trial shows superior clinical effectiveness of intact fish-skin grafts over standard care for ...

The trial compared hospital stay duration of severely burned patients treated with intact fish-skin grafts and patients treated with products that do not replicate the structure of native human tissue ...